Mon Oct 28 15:40:00 UTC 2024: ## Thousands of Cymbalta Bottles Recalled Due to Potential Cancer-Causing Chemical
**Washington, D.C.** – Over 7,100 bottles of the antidepressant Cymbalta (duloxetine) have been recalled due to the presence of N-nitroso duloxetine, a potentially carcinogenic chemical, according to the U.S. Food and Drug Administration (FDA).
The recall, initiated by manufacturer Towa Pharmaceutical Europe on October 10th, affects 20mg duloxetine delayed-release capsules, packaged in 500-count bottles with lot number 220128 and an expiration date of December 2024. The affected capsules were distributed nationwide within the United States.
The FDA categorized this recall as Class II, meaning that use of the recalled product could cause temporary or reversible health issues, with a low probability of serious adverse consequences.
While the FDA has advised patients not to stop taking their medication abruptly, they should consult with their healthcare provider about concerns and potential alternative treatments.
Towa Pharmaceutical Europe has stated that they are working with the FDA to identify the source of the N-nitroso duloxetine contamination and will keep the public informed.
The FDA continues to investigate nitrosamine impurities in various medications and emphasizes that patients should discuss any concerns with their healthcare provider.
First Piper 